BioWorld - Monday, April 6, 2026

Medical technology, Financings
Medical technology, Financings RSS Feed RSS

Cytoval 11B System Reagents

Cytovale raises $84M to commercialize sepsis diagnostic

Nov. 15, 2023
By Holland Johnson
The time to diagnosis of sepsis infection to a patient in the hospital can be critical, with underdiagnosis resulting in rapid deterioration, risk of organ damage and need for readmission, and overdiagnosis leading to the avoidable and sometimes serious health consequences of overtreating patients with broad-spectrum antibiotics.
Read More

Financings for Nov. 15, 2023

Nov. 15, 2023
Med-tech firms raising money in public or private financings, including: Femasys, Iqvia, Koya Medical, Lunit, Mainz Biomed, Movano, Ontrak, Reflexion.
Read More
Dollar sign and Euro symbol in cogwheels
Jefferies London Healthcare Conference

Jeffries says health care M&A activity expected to rise next year

Nov. 14, 2023
By Shani Alexander
Senior leaders and investors in the health care sector expect mergers and acquisitions (M&A) activity to continue to pick up next year but this will be corporate led rather than private equity, according to a report by global investment bank Jefferies. At the same time, many executives remained concerned about the lack of funding in the sector as it was identified as the number one threat.
Read More
LSX Investival Showcase

Funding environment continues to be difficult for med-tech startups

Nov. 13, 2023
By Shani Alexander

The funding environment continues to be challenging for companies in the health care sector, and even more so for early-stage med-tech companies, delegates heard at the LSX Investival Showcase in London. Med-tech companies were told that they had to be lean, constantly work on building relationships with investors and not to give up because there is money out there for innovative technologies that can save people’s lives.


Read More

Financings for Nov. 9, 2023

Nov. 9, 2023
Med-tech firms raising money in public or private financings, including: Apyx Medical, Biosig Technologies, Elucid Bioimaging, Myriad Genetics.
Read More
Acutus Acqmap

Acutus torches ablation business to focus on manufacturing

Nov. 9, 2023
By Annette Boyle
Acutus Medical Inc. revealed plans after the Nasdaq closing bell on Nov. 8 to abandon the electrophysiology business as part of a massive restructuring that will leave the company entirely committed to manufacturing and distribution of Medtronic plc’s left-heart access products. The shift will put 65% of Acutus employees out of work and leaves the future of its cardiac ablation and mapping products up in the air.
Read More